CLC bio Acquires the Drug Discovery-Software Company Molegro

Published: Sep 04, 2012

AARHUS, Denmark--(BUSINESS WIRE)--Today, CLC bio announced the acquisition of Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor, and determination of molecule similarity. The acquisition of Molegro supports CLC bio's strategy of continuously expanding their bioinformatics offerings beyond Next Generation Sequencing, as well as in bioinformatics areas of value to their customer base.

Back to news